<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    electroCore, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About electroCore, Inc.

    electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology and rheumatology. The company’s current indications are for the preventative treatment of cluster headache and acute treatment of migraine and episodic cluster headache. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $426,000,000
    • SIC CODE
      3845
    • NIN CODE
      ####
    • LEADERSHIP
      Francis R. Amato
    • FOUNDED
      2005
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Genprex, Inc.

    Genprex, Inc.

    Genprex Inc is a U.S.-based clinical-stage gene therapy company. It is engaged in ...

    Genprex Inc is a U.S.-based clinical-stage gene...

    Filing Type:    PU
    Correvio Pharma Corp.

    Correvio Pharma Corp.

    Correvio has two marketed, in-hospital, cardiology products: BRINAVESSÂŽ (vernakal...

    Correvio has two marketed, in-hospital, cardiol...

    Filing Type:    PU
    AC Immune SA

    AC Immune SA

    We are a clinical stage biopharmaceutical company leveraging our two proprietary t...

    We are a clinical stage biopharmaceutical compa...

    Filing Type:    PU
    DermTech, Inc.

    DermTech, Inc.

    DermTech is the global leader in molecular dermatology, bringing precision medicin...

    DermTech is the global leader in molecular derm...

    Filing Type:    PU
    Fresenius SE & Co. KGaA

    Fresenius SE & Co. KGaA

    Fresenius is a global healthcare group offering high-quality products and services...

    Fresenius is a global healthcare group offering...

    Filing Type:    PU
    Evogene Ltd.

    Evogene Ltd.

    Evogene (NASDAQ, TASE: EVGN) is a leading biotechnology company developing novel p...

    Evogene (NASDAQ, TASE: EVGN) is a leading biote...

    Filing Type:    PU
    Phoenix PharmaLabs Inc

    Phoenix PharmaLabs Inc

    Phoenix PharmaLabs, Inc. (PPL) is a privately held, pre-clinical stage drug develo...

    Phoenix PharmaLabs, Inc. (PPL) is a privately h...

    Amount Raised:    $1,079,375.00
    Fundraising Status:    EC
    Filing Type:    CF
    Recro Pharma, Inc.

    Recro Pharma, Inc.

    Recro Pharma (NASDAQ: REPH) is a revenue generating specialty pharmaceutical compa...

    Recro Pharma (NASDAQ: REPH) is a revenue genera...

    Filing Type:    PU
    Regeneron Pharmaceuticals, Inc.

    Regeneron Pharmaceuticals, Inc.

    We are a leading science and technology company that delivers life-transforming me...

    We are a leading science and technology company...

    Filing Type:    PU
    BioDelivery Sciences International, Inc.

    BioDelivery Sciences International, Inc.

    BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a rapidly growing comme...

    BioDelivery Sciences International, Inc. (NASDA...

    Filing Type:    PU
    Chiasma, Inc.

    Chiasma, Inc.

    Chiasma is focused on improving the lives of patients who face challenges associat...

    Chiasma is focused on improving the lives of pa...

    Filing Type:    PU
    Evelo Biosciences, Inc.

    Evelo Biosciences, Inc.

    Evelo Biosciences, Inc. is a clinical stage biotechnology company developing oral ...

    Evelo Biosciences, Inc. is a clinical stage bio...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.